A citation-based method for searching scientific literature

Colin B Begg, Irene Orlow, Amanda J Hummer, Bruce K Armstrong, Anne Kricker, Loraine D Marrett, Robert C Millikan, Stephen B Gruber, Hoda Anton-Culver, Roberto Zanetti, Richard P Gallagher, Terence Dwyer, Timothy R Rebbeck, Nandita Mitra, Klaus Busam, Lynn From, Marianne Berwick. J Natl Cancer Inst 2005
Times Cited: 148







List of co-cited articles
820 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Geographical variation in the penetrance of CDKN2A mutations for melanoma.
D Timothy Bishop, Florence Demenais, Alisa M Goldstein, Wilma Bergman, Julia Newton Bishop, Brigitte Bressac-de Paillerets, Agnès Chompret, Paola Ghiorzo, Nelleke Gruis, Johan Hansson,[...]. J Natl Cancer Inst 2002
342
57

High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Alisa M Goldstein, May Chan, Mark Harland, Elizabeth M Gillanders, Nicholas K Hayward, Marie-Francoise Avril, Esther Azizi, Giovanna Bianchi-Scarra, D Timothy Bishop, Brigitte Bressac-de Paillerets,[...]. Cancer Res 2006
286
28

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
Alisa M Goldstein, May Chan, Mark Harland, Nicholas K Hayward, Florence Demenais, D Timothy Bishop, Esther Azizi, Wilma Bergman, Giovanna Bianchi-Scarra, William Bruno,[...]. J Med Genet 2007
261
27

Selection criteria for genetic assessment of patients with familial melanoma.
Sancy A Leachman, John Carucci, Wendy Kohlmann, Kimberly C Banks, Maryam M Asgari, Wilma Bergman, Giovanna Bianchi-Scarrà, Teresa Brentnall, Brigitte Bressac-de Paillerets, William Bruno,[...]. J Am Acad Dermatol 2009
109
24


Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Roberto Zanetti, Cinzia Masini, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
452
21

The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
Marianne Berwick, Irene Orlow, Amanda J Hummer, Bruce K Armstrong, Anne Kricker, Loraine D Marrett, Robert C Millikan, Stephen B Gruber, Hoda Anton-Culver, Roberto Zanetti,[...]. Cancer Epidemiol Biomarkers Prev 2006
85
23

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
L Zuo, J Weger, Q Yang, A M Goldstein, M A Tucker, G J Walker, N Hayward, N C Dracopoli. Nat Genet 1996
616
20

Germline p16 mutations in familial melanoma.
C J Hussussian, J P Struewing, A M Goldstein, P A Higgins, D S Ally, M D Sheahan, W H Clark, M A Tucker, N C Dracopoli. Nat Genet 1994
19

Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.
Femke A de Snoo, D Timothy Bishop, Wilma Bergman, Inge van Leeuwen, Clasine van der Drift, Frans A van Nieuwpoort, Coby J Out-Luiting, Hans F Vasen, Jeanet A C ter Huurne, Rune R Frants,[...]. Clin Cancer Res 2008
120
18

Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Damiano Abeni, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
502
17

Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure.
Sara Gandini, Francesco Sera, Maria Sofia Cattaruzza, Paolo Pasquini, Orietta Picconi, Peter Boyle, Carmelo Francesco Melchi. Eur J Cancer 2005
761
17

Genetics of melanoma predisposition.
Nicholas K Hayward. Oncogene 2003
211
15

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Satoru Yokoyama, Susan L Woods, Glen M Boyle, Lauren G Aoude, Stuart MacGregor, Victoria Zismann, Michael Gartside, Anne E Cust, Rizwan Haq, Mark Harland,[...]. Nature 2011
286
15

MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations.
N F Box, D L Duffy, W Chen, M Stark, N G Martin, R A Sturm, N K Hayward. Am J Hum Genet 2001
220
14

Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
A M Goldstein, M C Fraser, J P Struewing, C J Hussussian, K Ranade, D P Zametkin, L S Fontaine, S M Organic, N C Dracopoli, W H Clark. N Engl J Med 1995
493
14

Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
A Kamb, D Shattuck-Eidens, R Eeles, Q Liu, N A Gruis, W Ding, C Hussey, T Tran, Y Miki, J Weaver-Feldhaus. Nat Genet 1994
527
14

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy, Karine Bille, Philippe Dessen, Benoit d'Hayer, Hamida Mohamdi, Audrey Remenieras,[...]. Nature 2011
339
14

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.
A Borg, T Sandberg, K Nilsson, O Johannsson, M Klinker, A Måsbäck, J Westerdahl, H Olsson, C Ingvar. J Natl Cancer Inst 2000
251
13

MC1R variants, melanoma and red hair color phenotype: a meta-analysis.
Sara Raimondi, Francesco Sera, Sara Gandini, Simona Iodice, Saverio Caini, Patrick Maisonneuve, Maria Concetta Fargnoli. Int J Cancer 2008
237
12

CDKN2A variants in a population-based sample of Queensland families with melanoma.
J Aitken, J Welch, D Duffy, A Milligan, A Green, N Martin, N Hayward. J Natl Cancer Inst 1999
160
12

ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma.
Daniel F Gudbjartsson, Patrick Sulem, Simon N Stacey, Alisa M Goldstein, Thorunn Rafnar, Bardur Sigurgeirsson, Kristrun R Benediktsdottir, Kristin Thorisdottir, Rafn Ragnarsson, Steinunn G Sveinsdottir,[...]. Nat Genet 2008
239
12

Genome-wide association study identifies three loci associated with melanoma risk.
D Timothy Bishop, Florence Demenais, Mark M Iles, Mark Harland, John C Taylor, Eve Corda, Juliette Randerson-Moor, Joanne F Aitken, Marie-Francoise Avril, Esther Azizi,[...]. Nat Genet 2009
337
12

Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
Hanne Eknes Puntervoll, Xiaohong R Yang, Hildegunn Høberg Vetti, Ingeborg M Bachmann, Marie Françoise Avril, Meriem Benfodda, Caterina Catricalà, Stéphane Dalle, Anne B Duval-Modeste, Paola Ghiorzo,[...]. J Med Genet 2013
81
14

Population-based analysis of prognostic factors and survival in familial melanoma.
Scott R Florell, Kenneth M Boucher, Gilda Garibotti, John Astle, Richard Kerber, Geraldine Mineau, Charles Wiggins, R Dirk Noyes, Alexander Tsodikov, Lisa A Cannon-Albright,[...]. J Clin Oncol 2005
69
15

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
N Soufir, M F Avril, A Chompret, F Demenais, J Bombled, A Spatz, D Stoppa-Lyonnet, J Bénard, B Bressac-de Paillerets. Hum Mol Genet 1998
310
11

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.
Robert R McWilliams, Eric D Wieben, Kari G Rabe, Katrina S Pedersen, Yanhong Wu, Hugues Sicotte, Gloria M Petersen. Eur J Hum Genet 2011
83
13

Germline mutations in BAP1 predispose to melanocytic tumors.
Thomas Wiesner, Anna C Obenauf, Rajmohan Murali, Isabella Fried, Klaus G Griewank, Peter Ulz, Christian Windpassinger, Werner Wackernagel, Shea Loy, Ingrid Wolf,[...]. Nat Genet 2011
473
11

Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma.
V Nikolaou, X Kang, A Stratigos, H Gogas, M C Latorre, M Gabree, M Plaka, C N Njauw, K Kypreou, I Mirmigi,[...]. Br J Dermatol 2011
29
37

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
11

High frequency of BRAF mutations in nevi.
Pamela M Pollock, Ursula L Harper, Katherine S Hansen, Laura M Yudt, Mitchell Stark, Christiane M Robbins, Tracy Y Moses, Galen Hostetter, Urs Wagner, John Kakareka,[...]. Nat Genet 2003
10


Association of MC1R variants and host phenotypes with melanoma risk in CDKN2A mutation carriers: a GenoMEL study.
F Demenais, H Mohamdi, V Chaudru, A M Goldstein, J A Newton Bishop, D T Bishop, P A Kanetsky, N K Hayward, E Gillanders, D E Elder,[...]. J Natl Cancer Inst 2010
77
12

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
Ching-Ni Jenny Njauw, Ivana Kim, Adriano Piris, Michele Gabree, Michael Taylor, Anne Marie Lane, Margaret M DeAngelis, Evangelos Gragoudas, Lyn M Duncan, Hensin Tsao. PLoS One 2012
173
10

Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
A M Goldstein, J P Struewing, A Chidambaram, M C Fraser, M A Tucker. J Natl Cancer Inst 2000
135
9

A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.
J A Randerson-Moor, M Harland, S Williams, D Cuthbert-Heavens, E Sheridan, J Aveyard, K Sibley, L Whitaker, M Knowles, J N Bishop,[...]. Hum Mol Genet 2001
209
9

A mutation hotspot at the p14ARF splice site.
Mark Harland, Claire F Taylor, Philip A Chambers, Kairen Kukalizch, Juliette A Randerson-Moor, Nelleke A Gruis, Femke A de Snoo, Jeanet A C ter Huurne, Alisa M Goldstein, Margaret A Tucker,[...]. Oncogene 2005
53
16

A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma.
Colin B Begg, Amanda J Hummer, Urvi Mujumdar, Bruce K Armstrong, Anne Kricker, Loraine D Marrett, Robert C Millikan, Stephen B Gruber, Hoda Anton Culver, Roberto Zanetti,[...]. Int J Epidemiol 2006
62
14

Genetic testing for melanoma.
Richard Kefford, Julia Newton Bishop, Margaret Tucker, Brigitte Bressac-de Paillerets, Giovanna Bianchi-Scarrá, Wilma Bergman, Alisa Goldstein, Susana Puig, Rona Mackie, David Elder,[...]. Lancet Oncol 2002
72
12

Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma.
H Tsao, X Zhang, K Kwitkiwski, D M Finkelstein, A J Sober, F G Haluska. Arch Dermatol 2000
64
14


Genome-wide association study identifies three new melanoma susceptibility loci.
Jennifer H Barrett, Mark M Iles, Mark Harland, John C Taylor, Joanne F Aitken, Per Arne Andresen, Lars A Akslen, Bruce K Armstrong, Marie-Francoise Avril, Esther Azizi,[...]. Nat Genet 2011
187
9

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
212
9

Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.
David C Whiteman, Peter Watt, David M Purdie, Maria Celia Hughes, Nicholas K Hayward, Adèle C Green. J Natl Cancer Inst 2003
289
8


Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma.
Peter A Kanetsky, Timothy R Rebbeck, Amanda J Hummer, Saarene Panossian, Bruce K Armstrong, Anne Kricker, Loraine D Marrett, Robert C Millikan, Stephen B Gruber, Hoda Anton Culver,[...]. Cancer Res 2006
96
8

CDKN2A mutations in multiple primary melanomas.
J Monzon, L Liu, H Brill, A M Goldstein, M A Tucker, L From, J McLaughlin, D Hogg, N J Lassam. N Engl J Med 1998
197
8

Does MC1R genotype convey information about melanoma risk beyond risk phenotypes?
Peter A Kanetsky, Saarene Panossian, David E Elder, DuPont Guerry, Michael E Ming, Lynn Schuchter, Timothy R Rebbeck. Cancer 2010
78
10

CDKN2A germline mutations in individuals with cutaneous malignant melanoma.
Irene Orlow, Colin B Begg, Javier Cotignola, Pampa Roy, Amanda J Hummer, Brian A Clas, Urvi Mujumdar, Rebecca Canchola, Bruce K Armstrong, Anne Kricker,[...]. J Invest Dermatol 2007
43
18

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.